2 studies found for:    21969517 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Phase 1 Study of PLX7486 as Single Agent and With Gemcitabine Plus Nab-Paclitaxel in Patients With Advanced Solid Tumors
Conditions: Solid Tumors;   Untreated Pancreatic Adenocarcinoma;   Pancreatic Cancer Non-resectable;   Metastatic Pancreatic Adenocarcinoma;   Tumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion Mutations
Interventions: Drug: PLX7486-TsOH;   Drug: gemcitabine;   Drug: nab-Paclitaxel
2 Completed
Has Results
Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: Albumin-bound paclitaxel

Indicates status has not been verified in more than two years